Bliss GVS Pharma Limited

NSE:BLISSGVS India Drug Manufacturers - Specialty & Generic
Market Cap
$257.29 Million
₹22.28 Billion INR
Market Cap Rank
#18105 Global
#846 in India
Share Price
₹210.76
Change (1 day)
+0.75%
52-Week Range
₹111.84 - ₹231.20
All Time High
₹231.20
About

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessarie… Read more

Bliss GVS Pharma Limited - Asset Resilience Ratio

Latest as of September 2025: 14.33%

Bliss GVS Pharma Limited (BLISSGVS) has an Asset Resilience Ratio of 14.33% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
₹2.01 Billion
Cash + Short-term Investments
Total Assets
₹14.00 Billion
All company assets
Resilience Assessment
Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Bliss GVS Pharma Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Bliss GVS Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₹1.96 Billion 13.97%
Short-term Investments ₹50.05 Million 0.36%
Total Liquid Assets ₹2.01 Billion 14.33%

Asset Resilience Insights

  • Moderate Liquidity: Bliss GVS Pharma Limited has 14.33% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Bliss GVS Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Bliss GVS Pharma Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Bliss GVS Pharma Limited (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Bliss GVS Pharma Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 10.06% ₹1.31 Billion ₹13.01 Billion -0.02pp
2024-03-31 10.07% ₹1.22 Billion ₹12.14 Billion +6.10pp
2023-03-31 3.97% ₹459.25 Million ₹11.57 Billion -6.98pp
2022-03-31 10.95% ₹1.21 Billion ₹11.09 Billion +6.18pp
2021-03-31 4.78% ₹514.25 Million ₹10.77 Billion +1.81pp
2020-03-31 2.96% ₹305.00 Million ₹10.29 Billion -5.03pp
2019-03-31 7.99% ₹723.24 Million ₹9.05 Billion +4.54pp
2018-03-31 3.45% ₹297.03 Million ₹8.60 Billion -3.14pp
2017-03-31 6.59% ₹650.03 Million ₹9.86 Billion +5.36pp
2016-03-31 1.23% ₹93.93 Million ₹7.62 Billion +0.97pp
2012-03-31 0.26% ₹8.03 Million ₹3.10 Billion -2.80pp
2006-03-31 3.06% ₹2.47 Million ₹80.79 Million -9.70pp
2005-03-31 12.76% ₹7.62 Million ₹59.75 Million --
pp = percentage points